BioSig Technologies Inc. completed private placement offerings, under which it issued 741,167 common shares and warrants to purchase 370,584 common shares to certain accredited investors.

The company raised proceeds of about $1.1 million.

Separately, the company also sold investors 426,667 units for a consideration of $640,000. Each unit comprises one common share and a warrant to purchase half of one common share. The warrants, which will expire April 6, 2020, are immediately exercisable and have an initial exercise price of $1.50 per share, payable in cash.